BioAesthetics Team Member
Ms. M. Sue Preston served as the Chief Executive Officer and President of Arriva Pharmaceuticals, Inc. She served as the Vice President of Global Regulatory Affairs at Chiron Corporation. Ms. Preston has more than 25 years of experience in implementing novel regulatory and quality strategies for timely product approvals. She served as Senior Vice President, Regulatory and Quality Affairs at Connetics since October 2000. Prior to joining Connetics, she spent seven years at Alpha Therapeutic Corporation with executive management responsibility in quality control, quality assurance, and regulatory affairs, as Corporate Vice President, Worldwide Regulatory Affairs. Before joining Alpha Therapeutic in 1993, Ms. Preston held various quality and regulatory positions with Baxter Healthcare, Neocrin, and Medarex. From 1980 to 1988, she worked in the Center for Biologics Evaluation and Research at the Food and Drug Administration. She serves as a Director of MiniVax, Inc. Ms. Preston received her B.A. from Lycoming College and did graduate work at American University and the University of Maryland.